Skip to main content
Vasundhara Rasayans Ltd. logo

Vasundhara Rasayans Ltd. — Investor Relations & Filings

Ticker · 538634 ISIN · INE406F01010 LEI · 984500L28B1K38AF3E48 BSE.NS Manufacturing
Open in API
Filings indexed 7 across all filing types
Latest filing 2026-05-28 Board/Management Inform…
Country IN India
Listing BSE.NS 538634

About Vasundhara Rasayans Ltd.

https://vrlindia.in/

Vasundhara Rasayans Ltd. specializes in the manufacturing and export of Active Pharmaceutical Ingredients (APIs), specifically focusing on antacid compounds. The product range includes Dried Aluminum Hydroxide Gel, Magnesium Hydroxide, Magnesium Trisilicate, and Magaldrate. These chemical entities are developed for use in medicinal formulations targeting gastrointestinal conditions. The company emphasizes adherence to quality standards and pharmacopoeial specifications to ensure the purity and efficacy of its chemical outputs. Operations are centered on the large-scale production of these specialized mineral salts for integration into diverse therapeutic products.

Recent filings

Filing Released Lang Actions
The Board of Directors in their meeting held on 28th May, 2026 appointed Mr. Ravi Jain as an Additional Director (Category- Non executive Independent Director) W.e.f 28th May, 2026
Board/Management Information Classification · 92% confidence The document is an official announcement under SEBI Listing Regulations informing the stock exchange of the appointment of a new Additional Director (Non-Executive Independent Director). It details the board’s decision, director’s term, profile, and regulatory references. This falls squarely under board/management changes, matching the Board/Management Information category (MANG).
2026-05-28 English
The Board of Directors in its meeting held on 28th May, 2026 has approved and taken on records the entering into of a Memorandum of Understanding cum Loan-lease agreement with PandJ Cretechem ....
Regulatory Filings Classification · 85% confidence The document is a stock exchange disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It notifies the BSE of the Board’s approval of a related‐party MoU/loan‐lease agreement. It is a regulatory announcement (continuous disclosure) rather than a full financial report, management discussion, or capital-raising notice. It does not include financial statements or require classification as an annual or interim report, nor is it a director change or dividend notice. Therefore, it falls under general Regulatory Filings.
2026-05-28 English
The Board of DIrectors of the Company in their meeting held on 28th May, 2026, reconstituted the Audit Committee, Nomination and Remuneration Committee and Stakeholders Relationship Committee ....
Board/Management Information Classification · 92% confidence The document is an official SEBI regulation 30 disclosure to the stock exchange, notifying the reconstitution (composition changes) of the Board’s Audit Committee, Nomination & Remuneration Committee, and Stakeholders Relationship Committee. This is a management/board change announcement rather than a financial report, dividend notice, or AGM materials. Therefore, it falls under Board/Management Information (MANG).
2026-05-28 English
This is to inform you about the retirement of Shri. Pradeep Kumar Jain from the position of Independent Director of the Director, consequent to the completion of his second term of five ....
Board/Management Information Classification · 92% confidence The document is an official stock exchange filing under SEBI LODR Regulation 30 notifying the completion of tenure/retirement of an independent director, including details of cessation and required annexure. It announces a board/management change rather than presenting financial data or minutes of AGM. Thus, it falls under Board/Management Information (MANG).
2026-05-28 English
Audited Financial Results for the Quarter and year ended on 31.03.2026
Interim / Quarterly Report Classification · 80% confidence The document is the formal SEBI ‘Outcome of the Board Meeting’ announcement in which the board (i) approves and takes on record the audited standalone financial results for the quarter and year ended March 31, 2026 – including full P&L tables – and (ii) encloses the Independent Auditor’s Report. It contains actual financial statements for a period shorter than a full fiscal year (quarterly plus year‐to‐date results) and substantive financial data, not merely summary highlights, and is not a full annual report. This matches our definition for an Interim/Quarterly Report rather than a simple earnings release or board appointment notice. Therefore, it should be classified as IR. FY 2026
2026-05-28 English
The Board of Directors of the Company, at their meeting held today, Thursday, 28th May 2026, inter alia, transacted the items of the agenda as attached
Interim / Quarterly Report Classification · 80% confidence The document is an outcome of the Board Meeting under SEBI Regulation 33, announcing and providing the audited standalone financial results for the quarter and financial year ended 31 March 2026, along with the independent auditor’s report and full financial statements. It contains actual financial data and substantive tables for a quarter period (and year-to-date figures). This aligns with the definition of an Interim/Quarterly Report (IR) rather than an Earnings Release (which only gives highlights), an Annual Report (10-K), or a mere announcement of a report (RPA). FY 2026
2026-05-28 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.